enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" Segment
-
US begins 'biggest ever' Philippines war games in thick of Mideast war
-
Anxiety lingers in divided Kashmir a year after shooting attack
-
Hit reality show helps rev up Japan's delinquent youth subculture
-
Oil prices bounce back on Iran war escalation
-
Residents return to ravaged homes months after Hong Kong fire
-
Australia's Green wins playoff for third LPGA LA Championship title
-
Pakistan's military chief takes lead on US-Iran talks in diplomatic blitz
-
Thunder, Celtics open NBA playoffs with big wins, Magic shock Pistons
-
US begins Philippines war games in thick of Middle East conflict
-
Who's Bad? Not Michael Jackson in new big-budget biopic
-
Nations gather for first-ever conference on fossil fuel exit
-
Money, lobbyists, inertia: why fossil fuels are so hard to quit
-
France summons Elon Musk over X probe
-
'Save humanity': Four figures battling it out to lead embattled UN
-
Gilgeous-Alexander, Wemby, Jokic finalists for NBA MVP
-
Israel vows to level homes in Lebanon, counter threats with 'full force'
-
Ameriwest Completes 3D Geological Model Defining High-Grade Copper Shell Along with Two Additional Zones at the Bornite Project
-
Genflow Biosciences PLC Announces Strategic Technology Collaboration
-
QNX and NVIDIA Deepen Collaboration to Advance Safety-Critical Edge AI Across Robotics, Medical, and Industrial Systems
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - April 20
-
401(k) to Gold IRA Rollover Guide Released (2026 Update)
-
Who Does the Best Deep Plane Facelift in Florida?
-
Rahm coasts to LIV Golf win in Mexico City
-
Fitzpatrick survives Scheffler playoff to win RBC Heritage
-
Thunder thrash Suns, Celtics crush Sixers in NBA playoff openers
-
Bulgaria's former president tops parliamentary vote
-
Kenyans Korir, Lokedi seek to repeat at Boston Marathon
-
AC Milan, Juventus close in on Champions League qualification
-
Spring double keeps Racing 92 in Top 14 play-off hunt with Paris derby win
-
Endrick stars as Lyon dent PSG's Ligue 1 title hopes
-
History haunts Arsenal as Man City take control of title race
-
AC Milan and Juventus close in on Champions League qualification
-
Celtics crush Sixers as Tatum and Brown shine in playoff opener
-
Guardiola warns title not won yet as Man City hunt down Arsenal
-
Arteta tells Arsenal to 'go again' in pursuit of Premier League title
-
Treble-chasing Bayern put beer showers on ice despite title win
-
Eight children dead in US domestic violence shooting
-
Arya, Connolly help Punjab hammer Lucknow in IPL
-
Man City beat Arsenal to seize control of title race, Liverpool win
-
Kane scores as Bayern sink Stuttgart to claim Bundesliga title
-
Balogun continues Monaco scoring streak, Rennes boost Champions League hopes
-
Trump orders negotiators to Pakistan, but Iran on the fence over talks
-
Haaland gives Man City edge over Arsenal in Premier League title showdown
-
Slot hails Liverpool mentality after last-gasp derby winner
-
Top boss vows 'no sitting still' as rugby bids to conquer US
-
Fils wins on Barcelona clay with French Open looming
-
'Super Mario Galaxy' rules N. America box office for third week
-
Liverpool snatch derby win ahead of City-Arsenal showdown
-
Evenepoel outsprints Skjelmose to win Amstel Gold Race
-
Liverpool beat Everton ahead of City-Arsenal showdown
enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" Segment
Watch the "What This Means" video here
IRVINE, CA / ACCESS Newswire / September 26, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous disease, today announced that Robert Berman, Chief Executive Officer of enVVeno Medical participated in a Virtual Investor "What This Means" segment.
As part of the segment, Mr. Berman discussed the Company's recent news announcing it filed a request for supervisory appeal of the not-approvable letter from the Center for Devices and Radiological Health (CDRH) of the U.S. Food & Drug Administration (FDA) received on August 19, 2025, in response to its Premarket Approval (PMA) application for the VenoValve®, a surgical replacement venous valve for treating severe deep chronic venous insufficiency (CVI).
The Virtual Investor "What This Means" segment featuring enVVeno Medical is now available here.
About enVVeno Medical Corporation
enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device Company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of deep venous disease. The Company's lead product, the VenoValve®, is a first-in-class surgical replacement venous valve being developed for the treatment of severe deep Chronic Venous Insufficiency (CVI). The Company is also developing a non-surgical, transcatheter based replacement venous valve for the treatment of deep venous CVI called enVVe®. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the leg, and back to the heart and lungs. The Company is currently performing the final testing necessary to seek IDE approval from the FDA to begin the U.S. pivotal trial for enVVe.
INVESTOR CONTACT:
Jenene Thomas, JTC Team, LLC
[email protected]
(908) 824-0775
MEDIA CONTACT:
Glenn Silver, FINN Partners
[email protected]
(973) 818-8198
SOURCE: enVVeno Medical Corporation
View the original press release on ACCESS Newswire
Y.Nakamura--AMWN
